RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been certified to be interoperable with Varian TrueBeam linear accelerators

May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been certified to be interoperable with Varian TrueBeam linear accelerators, version 3.0. This is the result of joint testing activities between RaySearch and Varian Medical Systems during 2024.

In May 2023, RayCare 5B was certified to be interoperable with TrueBeam 3.0. This was 17 months after the release of RayCare 5B. The interoperability certificate for 2024A that was issued now comes already before the release of RayCare 2024A which is scheduled to be finalized in a few weeks from now.

TrueBeam is Varian’s most prevalent treatment delivery platform and has been installed in thousands of radiation therapy clinics in the world since its launch in 2010. It supports all treatment techniques and capabilities that are provided by so called c-arm linacs, including IMRT, VMAT and electrons with flexible beam energy selection and non-coplanar beam arrangements. The interoperability certificate applies to linacs in the TrueBeam family equipped with kV imaging: TrueBeam, TrueBeam STx, Edge and VitalBeam.

Agam Sharda, VP of Product & Portfolio Management at Varian, says: “By achieving clinical interoperability between TrueBeam and RayCare, Varian again shows our commitment to developing, deploying, and maintaining critical interfaces for our fleet to operate seamlessly. RaySearch as an alliance in our ecosystem program is another example of our resolve to meet the diverse needs of customers across the world.”

Johan Löf, founder and CEO, RaySearch, says: “Interoperability with treatment delivery systems is a key feature of RayCare and it is gratifying to see that the interoperability of the latest version of RayCare with TrueBeam has been achieved in time for the release and I look forward to clinical implementation of the connection later in 2024.”   

* Subject to regulatory clearance in some markets.

For more information: www.raysearchlabs.com


Related Content

News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 11, 2024 — Artificial Intelligence (AI) tools can play a key role in medical imaging if radiologists trust in their ...

Time July 11, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 09, 2024
arrow
Subscribe Now